Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

Vimpat (lacosamide) Now Approved by FDA for Primary Generalized Tonic-Clonic Seizures and Expanded Pediatric Use for People Living with Epilepsy

ATLANTA, Nov. 17, 2020 /PRNewswire/ — UCB, a global pharmaceutical company, today announced th...
read more
Rates of VTE, major bleeding high in primary CNS lymphoma

Rates of VTE, major bleeding high in primary CNS lymphoma

(HealthDay)—For patients with primary central ne...
read more
Age is a primary determinant of melanoma treatment resistance, two studies find

Age is a primary determinant of melanoma treatment resistance, two studies find

Age may cause identical cancer cells with the same...
read more
Online intervention may cut unnecessary primary care visits

Online intervention may cut unnecessary primary care visits

(HealthDay)—An online intervention may be effect...
read more
Eight questions helpful for assessing IBD in primary care

Eight questions helpful for assessing IBD in primary care

(HealthDay)—The CalproQuest, an eight-item quest...
read more